Evidence level for effectiveness of glucagon-like peptide-1 receptor agonists respectively sodium glucose co-transporter-2 inhibitors for mitochondrial diabetes is low
- Josef Finsterer, MD, PhD*, Marlies Frank, MD
Josef Finsterer, MD, PhD*, Marlies Frank, MD
Krankenanstalt Rudolfstiftung, Messerli Institute, Austria
Search for the other articles from the author in:
Google Scholar | PubMed | BMJ Journal
Cite this:
[1]
Josef Finsterer, MD, PhD*, Marlies Frank, MD, “Evidence level for effectiveness of glucagon-like peptide-1 receptor agonists respectively sodium glucose co-transporter-2 inhibitors for mitochondrial diabetes is low”, ijmhs, vol. 10, no. 06, pp. 959–960, Jun. 2020.
© 2022 Interactive Protocols
Share
PDF